Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-002 and DA-005 for Hair Loss
NCT06501924Phase 3Withdrawn
- Start
- Jan 2027
- Primary completion
- Oct 2027
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
01
Overview
A Phase 3 trial of DA-005, DA-002 in androgenetic alopecia (AGA). Planned start Jan 2027; status: withdrawn.
02
Drugs
DA-005DA-002
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06501924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06501924.